RAPID-19 Study

RAPID-19 — Repository of Aggregated Pediatric International Data on COVID-19

Our Mission

Multiple pediatric registries, observational studies, and clinical trials have been launched to study COVID-19 in pediatric patients. In order to maximize efforts and augment collective resources, workflows are needed to facilitate aggregation and standardization of de-identified clinical data on pediatric patients with lab-confirmed COVID-19 across healthcare sites and study networks.

We are a team of pediatricians, scientists, network leaders, and informaticians who have joined forces to build a platform that offers an integrated database and analytics hub to enable the secure sharing of existing de-identified patient-level data and promote the standardization of new data collection. The goal is to support multi-national observational studies on disease trajectory and clinical care delivery for pediatric patients with COVID-19.

The Repository of Aggregated Pediatric International Data on COVID-19 (RAPID-19) is intended to support a broad range of research topics and questions, including but not limited to:

  • clinical characterization of pediatric patients with COVID-19
  • descriptive analysis of clinical care and treatments administered
  • evaluation of laboratory tests for diagnosis and disease monitoring
  • identification of patient sub-groups at higher risk for severe disease manifestations
  • ascertainment of country-specific variations
The commitment and compassion with which we care for all children and families is matched only by the pioneering spirit of discovery and innovation that drives us to think differently, to find answers, and to build a better tomorrow for children everywhere.

Kevin B. Churchwell, President and CEO

Connect with Boston Children's Hospital